Cargando…
Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson’s Disease
Parkinson’s disease (PD) is characterized by resting tremor, rigidity and bradykinesia. Dopaminergic medications such as L-dopa treat these motor symptoms, but can have complex effects on cognition. Impulse control is an essential cognitive function. Impulsivity is multifaceted in nature. Motor impu...
Autores principales: | Yang, Xue Q., Lauzon, Brian, Seergobin, Ken N., MacDonald, Penny A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758505/ https://www.ncbi.nlm.nih.gov/pubmed/29354045 http://dx.doi.org/10.3389/fnhum.2017.00642 |
Ejemplares similares
-
Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers
por: Yang, Xue Qing, et al.
Publicado: (2016) -
Adaptive Strategies for the Elderly in Inhibiting Irrelevant and Conflict No-Go Trials while Performing the Go/No-Go Task
por: Hsieh, Shulan, et al.
Publicado: (2016) -
Dopaminergic therapy affects learning and impulsivity in Parkinson’s disease
por: Hiebert, Nole M, et al.
Publicado: (2014) -
Dopaminergic medication impairs feedback-based stimulus-response learning but not response selection in Parkinson's disease
por: Vo, Andrew, et al.
Publicado: (2014) -
Valuation of Go Stimuli or Devaluation of No-Go Stimuli? Evidence of an Increased Preference for Attended Go Stimuli Following a Go/No-Go Task
por: Inoue, Kazuya, et al.
Publicado: (2017)